Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...

Tabelecleucel shows promising efficacy in treating EBV-positive PTLD, offering hope for patients resistant to previous ...

Now that Ultomiris has matched the indications of its predecessor Soliris, AstraZeneca is eyeing new avenues for the C5 drug ...

Epkinly (epcoritamab) is a subcutaneously delivered CD3×CD20 BiTE that secured FDA accelerated approval in 2023 for r/r DLBCL.

The BM12 CAST trial, a major clinical trial led by the Australasian Leukaemia & Lymphoma Group (ALLG) across New Zealand and Australian hospitals, will transform global blood stem cell transplant ...

By the end of the 4-0 loss to the Atlanta Braves in the opener of a four-game series, his arm was in a splint, and he was preparing for a flight back to Cincinnati Tuesday morning for surgery.

Last fall, the 29-year-old came to the Hospital of the University of Pennsylvania from his home in Switzerland for a rare ...

Two posters presented at the 2025 European Hematology Association Congress support combination therapy with daratumumab, ...